Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently... see more

OTCPK:ARLZQ - Post Discussion

Old API Wind-down Ltd - Ordinary Shares > Adams just broke even...
View:
Post by kuatolives on Sep 12, 2016 11:56am

Adams just broke even...

....
Comment by Bigboyone on Sep 12, 2016 12:01pm
I promised myself I wasnt going to look..but its like driving by an accident, you think not to look but you do.. All my Bells and whistles for my Aralez Charts green, I am sure all these day traders, funds, any one who has a trading kit, see's whats going on, breaking the ARALEZ 52 week high was huge!!!! I see $8.00 real quick, would rather have approval on the 14th, so we get another day run, ...more  
Comment by PoorOpinion on Sep 12, 2016 4:43pm
I'm looking on the fda website but see no approvals for the 12th Sept https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Reports.MonthlyApprovalsAll It does look like there are usually multiple approvals each day so possible the data for today hasnt been added. Does anybody know if there's a certain time when this list gets updated? Is it end of day? GL everybody ...more  
Comment by Bigboyone on Sep 12, 2016 5:42pm
I think your date maybe off, we are talking September 14th 2016. I am a bit disapointed in the 2.5 Mil  volume into the close with 55c off of the days high. There was nothing posing any resistance above $6.70- The day traders all had green buy signals. We have traded 3/4 the (Supposed Tradeable) Shrs the last 2.5 weeks. I am just hoping the institutions are heging against a possible No pass ...more  
Comment by kuatolives on Sep 12, 2016 6:51pm
No clue, but my prediction (assuming approval) is a runup followed by a few sellofs - followed by more runups - followed by more sellofs, until the traders go home and the investors are settled in. The boys don't mind taking their profits on this stock, so you still see some noticeable price drops from time to time. It's my guess there are a few institutions who simply can't buy this ...more  
Comment by PoorOpinion on Sep 12, 2016 6:58pm
Thanks, yeah had 12 th in my head. Gives me time to monitor that website
Comment by Floridas2000 on Sep 12, 2016 12:06pm
Looks like the approval is almost a sure thing at this point.  The market is acting that way and you know how information is always leaked.
Comment by kuatolives on Sep 12, 2016 12:07pm
Was thinking the same thing (about the information leak). Someone in the FDA knows, which means someone on Wall Street knows ....
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities